预约演示
更新于：2026-05-18
Pazufloxacin Mesilate
甲磺酸帕珠沙星
更新于：2026-05-18
概要
基本信息
非在研机构- |
权益机构- |
最高研发阶段批准上市 |
首次获批日期 日本 (2002-04-11), |
最高研发阶段(中国)批准上市 |
特殊审评- |
登录后查看时间轴
结构/序列
分子式C17H19FN2O7S |
InChIKeyUDHGFPATQWQARM-FJXQXJEOSA-N |
CAS号163680-77-1 |
关联
10
项与 甲磺酸帕珠沙星 相关的临床试验NCT03696342
Clinical Study of the Efficacy of the Ophthalmic Solution of Pazufloxacin 0.6% (PRO-157) for the Treatment of Acute Bacterial Conjunctivitis, Compared to the Ophthalmic Solution of Gatifloxacin 0.3%.
NCT03675841
A Phase I，Pazufloxacin Mesilate Ear Drops in Patients With Chronic Suppurative Otitis Media
NCT02592096
A Single Dose Phase I Clinical Study of Pazufloxacin Mesilate Ear Drops for the Patients With Otitis Media
100 项与 甲磺酸帕珠沙星 相关的临床结果
登录后查看更多信息
100 项与 甲磺酸帕珠沙星 相关的转化医学
登录后查看更多信息
100 项与 甲磺酸帕珠沙星 相关的专利（医药）
登录后查看更多信息
224
项与 甲磺酸帕珠沙星 相关的文献（医药）2026-02-01JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
Chiral separation of fluoroquinolones by capillary electrophoresis using glucosamine-functionalized carbon quantum dots as a Pseudostationary phase
Article
作者: Wu, Guoli ; Li, Chen ; Zhang, Yue ; Qu, Tingli
Fluoroquinolones are a class of widely used antibiotics, most of which contain chiral centers. Significant differences exist between their enantiomers in terms of antimicrobial activity, pharmacokinetics, and toxicity. In this study, glucosamine chiral-functionalized carbon quantum dots (GA-CQDs) were successfully synthesized and employed as a pseudostationary phase. By optimizing the chromatographic conditions, an efficient and novel chiral separation platform based on capillary electrophoresis (CE) was established for the enantioseparation of six fluoroquinolones. Compared to the CE system using free glucosamine solely as the chiral selector, the CE system employing GA-CQDs as a pseudostationary phase demonstrated a substantial improvement in chiral resolution (Rs) for all six model analytes (Ofloxacin: 1.56 → 9.21; Pazufloxacin: 0 → 8.53; Prulifloxacin: 1.38 → 7.58; Lomefloxacin: 1.01 → 2.84; Gemifloxacin: 0 → 1.25; Balofloxacin: 0 → 0.88). The incorporation of the pseudostationary phase significantly enhanced the chiral separation capability. This proposed strategy is characterized by its operational simplicity and low cost, thereby offering a valuable conceptual framework and a highly promising approach for developing chiral separation methods for fluoroquinolone antibiotics. This study represents the first report on employing GA-CQDs as a chiral selective medium to construct a capillary electrophoresis system, which achieved satisfactory enantioselectivity. Furthermore, the chiral recognition mechanism of glucosamine was preliminarily investigated through molecular modeling simulations, with the binding energy providing insights into the separation process.
2025-12-01Acta Crystallographica Section C-Structural Chemistry
Chloride salts of the antibacterial agent pazufloxacin: (H
3
O)
2
(Pzfx)
5
Cl
7
·10H
2
O and (Pzfx)Cl·1.75H
2
O·0.5C
2
H
5
OH
Article
作者: Dorovatovskii, Pavel V ; Vologzhanina, Anna V ; Tselukovskaya, Ekaterina D
Recrystallization of pazufloxacinium mesylate from HCl solutions yielded two previously unknown salts of pazufloxacin. These were characterized by X-ray diffraction and are bis(oxidanium) pentakis[(2
S
)-6-(1-azaniumylcyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0
5,13
]trideca-5(13),6,8,11-tetraene-11-carboxylic acid] heptachloride decahydrate, 2H
3
O
+
·5C
16
H
16
FN
2
O
4+
·7Cl
−
·10H
2
O (
1
), and (2
S
)-6-(1-azaniumylcyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.0
5,13
]trideca-5(13),6,8,11-tetraene-11-carboxylic acid chloride ethanol hemisolvate 1.75-hydrate, C
16
H
16
FN
2
O
4+
·Cl
−
·0.5C
2
H
6
O·1.75H
2
O (
2
), which were obtained from acetonitrile and ethanol, respectively. The compounds crystallize in the noncentrosymmetric triclinic space group
P
1. Salt
1
contains five independent cations and seven chloride anions, while compound
2
contains eight independent cations and anions. In both, an intramolecular COOH...O=C hydrogen bond is present and the amino group is protonated. The cations, anions and solvent molecules form extensive hydrogen-bonded frameworks. In addition, in both structures, the cations are packed into infinite stacks
via
π–π interactions, with interplanar distances of approximately 3.2 Å.
2025-08-01SEPARATION AND PURIFICATION TECHNOLOGY
Environmentally friendly synthesis of quasi-MIL-100(Fe) with modulation defects for efficient photo-Fenton degradation of ciprofloxacin
作者: Ma, Xianyun ; Zhang, Sanbing ; Liu, Yajia ; Miao, Chang-qing ; Zhu, Bowen ; Wang, Min ; Li, Zuopeng
Defect engineering is a promising approach for constructing highly efficient catalytic activity based on metal-organic frameworks (MOFs).In this study, a defective MOFs, referred to as quasi-MIL-100(Fe), was synthesized by moderate synthesis method and then careful thermal treatment at an atm. ranging from 150 to 450°C, linking crystalline materials and the associated metal oxides.MIL-100(Fe) heat-treated at 250°C (referred to as M-250) partially breaks coordination bonds, resulting in a crystalline-to-amorphous transformation, increased porosity, and elimination of ligands.Compared to pristine MIL-100(Fe), M-250 possessed more reactive sites and exhibited the highest photo-Fenton degradation of ciprofloxacin with 95.6% removal efficiency in 90 min, despite the unfavorable photo properties for photo-Fenton performance due to the destruction of the crystal structure.Addnl., d. functional theory (DFT) calculations, combined with free radical quenching and mass spectrometry anal., elucidated the catalytic mechanism.These findings highlight the significant potential of quasi-MOFs for applications in the photo-Fenton reaction.
100 项与 甲磺酸帕珠沙星 相关的药物交易
登录后查看更多信息
研发状态
批准上市
10 条最早获批的记录, 后查看更多信息
登录
| 适应症 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|
| 感染 | 中国 | 2004-01-01 | |
| 细菌感染 | 日本 | 2002-04-11 |
未上市
10 条进展最快的记录, 后查看更多信息
登录
| 适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
|---|---|---|---|---|
| 慢性化脓性中耳炎 | 临床1期 | 中国 | 2015-07-24 |
登录后查看更多信息
临床结果
临床结果
适应症
分期
评价
查看全部结果
临床3期 | 46 | (PRO-157) | 簾憲簾鏇願網網餘窪壓 = 選淵窪壓製網醖鹹膚壓 膚窪積鬱夢積餘艱鹹餘 (築願膚範選糧簾襯觸觸, 觸觸觸鬱齋壓願簾鏇鬱 ~ 襯蓋鏇願願構壓蓋襯製) 更多 | - | 2021-08-24 | ||
(Zymar) | 簾憲簾鏇願網網餘窪壓 = 憲願膚醖餘積憲網鑰壓 膚窪積鬱夢積餘艱鹹餘 (築願膚範選糧簾襯觸觸, 衊簾窪網艱廠憲鑰窪襯 ~ 憲範壓範繭餘遞顧簾窪) 更多 | ||||||
临床2期 | 150 | (PRO-157 BID (2 Times Per Day)) | 繭鑰選膚鏇餘選觸窪製 = 窪窪廠築餘糧糧顧鏇衊 願遞簾蓋蓋簾襯鹽壓積 (膚膚遞願憲艱鬱齋鹹憲, 積糧遞壓鬱顧齋鹹鏇餘 ~ 壓鹹繭窪窪範鬱鑰築願) 更多 | - | 2019-02-15 | ||
(PRO-157 TID (3 Times Per Day)) | 繭鑰選膚鏇餘選觸窪製 = 網餘築網餘膚鹽選鹽鏇 願遞簾蓋蓋簾襯鹽壓積 (膚膚遞願憲艱鬱齋鹹憲, 鏇積鏇鏇憲製鹹膚簾襯 ~ 壓餘衊餘鏇醖夢糧網觸) 更多 | ||||||
临床2期 | 300 | 構艱選衊蓋繭糧淵網鏇(獵遞繭餘夢願鹽願繭鬱) = 齋築窪蓋網鑰獵製壓衊 獵鹽艱鬱鹽齋衊鹽鹽構 (醖範鹹廠觸製鏇範簾壓 ) | 积极 | 2017-05-07 | |||
構艱選衊蓋繭糧淵網鏇(獵遞繭餘夢願鹽願繭鬱) = 鏇膚遞憲蓋鹽艱鏇鏇蓋 獵鹽艱鬱鹽齋衊鹽鹽構 (醖範鹹廠觸製鏇範簾壓 ) |
登录后查看更多信息
转化医学
使用我们的转化医学数据加速您的研究。
登录
或
药物交易
使用我们的药物交易数据加速您的研究。
登录
或
核心专利
使用我们的核心专利数据促进您的研究。
登录
或
临床分析
紧跟全球注册中心的最新临床试验。
登录
或
批准
利用最新的监管批准信息加速您的研究。
登录
或
特殊审评
只需点击几下即可了解关键药物信息。
登录
或
生物医药百科问答
全新生物医药AI Agent 覆盖科研全链路，让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。
生物序列数据库
生物药研发创新
免费使用
化学结构数据库
小分子化药研发创新
免费使用